Essential website updates between 07:00-07:15am CET 14 February 2025 may cause disruption.
Approvals are a subset of commitments for which funding availability and programme performance has been assessed as satisfactory. Only such approved amounts can be disbursed subject to all other conditions for disbursement being met by the countries. Approvals are typically granted for the current year and one further year.
Commitments represent endorsements of multi-year programme budgets made by the Gavi Board, Executive Committee or the CEO. These endorsements do not constitute a liability to pay but instead send a positive signal that Gavi intends to fund a programme over its entire life span subject to performance and availability of funds.
Disbursements by 'Programme Year' in the graph shows the payments made from 2020 up to the date of the report. The payments are shown by the programme year to which they relate irrespective of the calendar year in which they were made. The programme year is the year in which the relevant vaccine/cash programme is being implemented.
Annual figures may reflect negative values due to refunds from previous years or allocation of prepayments to reflect actual apportionment by country.
Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
This Gavi country data is made available under the Creative Commons BY 4.0 license: https://creativecommons.org/licenses/by/4.0/
Indonesia pledges US$ 30 million to support global immunisation efforts through Gavi
Indonesia becomes a new Gavi donor with pledge of US$ 30 million for Gavi’s 2026–2030 strategic period, “Gavi 6.0”.
Over the next few years, Gavi, the Vaccine Alliance and partners will focus efforts to revitalise access to the human papillomavirus (HPV) vaccine to reach 86 million adolescent girls, rapidly recover and improve coverage, and help build…
Gavi’s first multisectoral private sector partnership to include nutrition as part of holistic approach to disease prevention.
Indonesia and Senegal to co-host 2022 Gavi COVAX AMC Summit, together with Germany
The governments holding the presidencies of the G7, the G20 and the African Union will co-host a summit to raise new urgent funding for global vaccination in lower-income economies, a sign of renewed international cooperation and a continued…
Indonesia introduces Pneumococcal Conjugate Vaccine (PCV) across the country
Jakarta/Geneva, 30 June 2021 – Up to 4.5 million children across Indonesia will be protected against the most common cause of severe pneumonia every year, after the introduction of Pneumococcal Conjugate Vaccine (PCV) into the country’s routine…
Protecting children from the most-deadly infectious disease in Indonesia
Affordable vaccines mean more children can now be protected from pneumonia.
The state of the world’s sanitation
To achieve universal sanitation, we need greater investment and higher rates of sanitation coverage.
Digitizing vaccine cold chain, key to post-pandemic immunization in Indonesia
For some vaccinators in the vast archipelagic nation of Indonesia, a day in their professional life may involve trekking through deep tropical valleys and jungles or crossing the open waters on rickety boats to isolated islands.
Name | Source | Date |
---|---|---|
Total population | United Nations, World Population Prospects (UN WPP), July 2024 release. | 2024-07-11 |
Birth cohort (Total number of live births) | United Nations, World Population Prospects (UN WPP), July 2024 release. | 2024-07-11 |
Surviving infants (# of children surviving to 1 year) | United Nations, World Population Prospects (UN WPP), July 2024 release. | 2024-07-11 |
Infant mortality rate (deaths < 1 year per 1000 births) | UN Inter-agency Group for Child Mortality Estimation (UN IGME), March 2024 release. | 2024-04-15 |
Child mortality rate (deaths < 5 years per 1000 births) | UN Inter-agency Group for Child Mortality Estimation (UN IGME), March 2024 release. | 2024-04-15 |
GNI per capita, Atlas method (current US$) | World Bank national accounts data, and OECD National Accounts data files, July 2024 release. | 2024-07-01 |
Number of zero-dose children | WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), July 2024 release; figures calculated using number of surviving infants from UN World Population Prospects (UN WPP) | 2024-07-15 |
% reduction in number of zero-dose children, 2019-2023 | WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), July 2024 release; figures calculated using number of surviving infants from UN World Population Prospects (UN WPP) | 2024-07-15 |
DTP1/DTP3/MCV1 coverage (%) | WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), July 2024 release. | 2024-07-15 |
Drop out from DTP1 to DTP3 | WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), July 2024 release | 2024-07-15 |
Drop out from DTP1 to last routine dose of MCV | WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), July 2024 release. | 2024-07-15 |
Geographic equity of DTP3 coverage: DTP3 coverage in the 20% of districts with lowest coverage | WHO/UNICEF Joint Reporting Form (JRF), July 2024 release. | 2024-07-05 |